(Q38429723)

3 September 2017

Plasma membrane protein profiling in beta-amyloid-treated microglia cell line (English)

1 reference

3 September 2017

0 references

1 reference

Virginia Correani

1

1 reference

3 September 2017

Laura Di Francesco

2

1 reference

3 September 2017

Giuseppina Mignogna

3

1 reference

3 September 2017

Cinzia Fabrizi

4

1 reference

3 September 2017

Stefano Leone

5

1 reference

3 September 2017

Alessandra Giorgi

6

1 reference

3 September 2017

Alessia Passeri

7

1 reference

3 September 2017

Roberto Casata

8

1 reference

3 September 2017

Lorenzo Fumagalli

9

1 reference

3 September 2017

Bruno Maras

10

1 reference

3 September 2017

M Eugenia Schininà

11

1 reference

3 September 2017

16 August 2017

1 reference

3 September 2017

1 reference

Microglia in Physiology and Disease.

3 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

A polarizing question: do M1 and M2 microglia exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Deciphering microglial diversity in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Microglial Aβ receptors in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

14-3-3ε marks the amyloid-stimulated microglia long-term activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Amyloid-beta-activated human microglial cells through ER-resident proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Reversible redox modifications in the microglial proteome challenged by beta amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Acetylation and phosphorylation of STAT3 are involved in the responsiveness of microglia to beta amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Integration of a two-phase partition method into proteomics research on rat liver plasma membrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Aqueous polymer two-phase systems for the proteomic analysis of plasma membranes from minute brain samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Involvement of the intracellular ion channel CLIC1 in microglia-mediated beta-amyloid-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Preparing synthetic Aβ in different aggregation states

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

MaxQuant for in-depth analysis of large SILAC datasets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Andromeda: a peptide search engine integrated into the MaxQuant environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Semaphorin 3A-Plexin-A1 signaling through ERK activation is crucial for Toll-like receptor-induced NO production in BV-2 microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's A beta(1--42) and A beta(25--35).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

PARP-1 modulates amyloid beta peptide-induced neuronal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Repeated intra-hippocampal injection of beta-amyloid 25–35 induces a reproducible impairment of learning and memory: considering caspase-3 and MAPKs activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Microglia receptors and their implications in the response to amyloid β for Alzheimer's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Involvement of Fc receptors in disorders of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

TLR2 is a primary receptor for Alzheimer's amyloid β peptide to trigger neuroinflammatory activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Mechanisms involved in α1B-adrenoceptor desensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Desensitization by different strategies of epidermal growth factor receptor and ErbB4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Low-density lipoprotein receptor-related protein 1 is a novel modulator of radial glia stem cell proliferation, survival, and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

2'-Hydroxycinnamaldehyde targets low-density lipoprotein receptor-related protein-1 to inhibit lipopolysaccharide-induced microglial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

LRP1 modulates the microglial immune response via regulation of JNK and NF-κB signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

IFITM3 restricts the morbidity and mortality associated with influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

A diverse range of gene products are effectors of the type I interferon antiviral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Astroglial IFITM3 mediates neuronal impairments following neonatal immune challenge in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Regulation of the trafficking and antiviral activity of IFITM3 by post-translational modifications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Kinase associated-1 domains drive MARK/PAR1 kinases to membrane targets by binding acidic phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Regulation of the polarity kinases PAR-1/MARK by 14-3-3 interaction and phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Role of individual MARK isoforms in phosphorylation of tau at Ser²⁶² in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer's disease granulovacuolar degeneration bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Annexins: from structure to function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Annexin-phospholipid interactions. Functional implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Annexin 5 and apolipoprotein E2 protect against Alzheimer's amyloid-beta-peptide cytotoxicity by competitive inhibition at a common phosphatidylserine interaction site

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Neuropilin Functions as an Essential Cell Surface Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Function of members of the neuropilin family as essential pleiotropic cell surface receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201600439

21 January 2018

Identifiers

DOI

10.1002/PMIC.201600439

1 reference

3 September 2017

1 reference